Baynes Roy D.
CIK 1680739
Transactions on file
38
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-01 | 2026-06-26 | NTRA Natera, Inc. | Grant | 75 | $0.00 | — | open → | |
| 2026-07-01 | 2026-06-26 | NTRA Natera, Inc. | Grant | 1,571 | $0.00 | — | open → | |
| 2026-06-16 | 2026-06-12 | TVTX Travere Therapeutics, Inc. | Sale | 4,500 | $225.0K | +32.1% | open → | |
| 2026-06-16 | 2026-06-12 | TVTX Travere Therapeutics, Inc. | Exer. | 4,500 | $96.2K | +209.0% | open → | |
| 2026-05-21 | 2026-05-19 | TVTX Travere Therapeutics, Inc. | Grant | 4,000 | $0.00 | — | open → | |
| 2026-04-28 | 2026-04-24 | NTRA Natera, Inc. | Grant | 83 | $0.00 | — | open → | |
| 2026-04-16 | 2026-04-14 | TVTX Travere Therapeutics, Inc. | Sale | 6,750 | $284.3K | +56.9% | open → | |
| 2026-04-16 | 2026-04-14 | TVTX Travere Therapeutics, Inc. | Sale | 26,000 | $1.07M | +60.9% | open → | |
| 2026-04-16 | 2026-04-14 | TVTX Travere Therapeutics, Inc. | Exer. | 6,750 | $115.5K | +286.1% | open → | |
| 2026-04-16 | 2026-04-14 | TVTX Travere Therapeutics, Inc. | Exer. | 4,500 | $96.2K | +209.0% | open → | |
| 2026-04-16 | 2026-04-14 | TVTX Travere Therapeutics, Inc. | Exer. | 4,500 | $82.2K | +261.6% | open → | |
| 2026-04-16 | 2026-04-14 | TVTX Travere Therapeutics, Inc. | Exer. | 9,000 | $138.9K | +328.2% | open → | |
| 2026-04-16 | 2026-04-14 | TVTX Travere Therapeutics, Inc. | Exer. | 8,000 | $143.5K | +268.3% | open → | |
| 2025-01-23 | 2025-01-23 | TVTX Travere Therapeutics, Inc. | Director | Sale | 16,000 | $320.0K | +230.3% | open → |
| 2025-01-23 | 2025-01-23 | TVTX Travere Therapeutics, Inc. | Director | Exer. | 16,000 | $280.0K | +277.5% | open → |
| 2025-02-04 | 2025-01-31 | NTRA Natera, Inc. | Director | Grant | 92 | — | — | open → |
| 2025-02-10 | 2025-02-06 | TVTX Travere Therapeutics, Inc. | Director | Sale | 10,000 | $220.0K | +200.3% | open → |
| 2025-02-10 | 2025-02-06 | TVTX Travere Therapeutics, Inc. | Director | Exer. | 10,000 | $174.4K | +278.8% | open → |
| 2025-04-29 | 2025-04-25 | NTRA Natera, Inc. | Director | Grant | 116 | — | — | open → |
| 2025-05-16 | 2025-05-15 | TVTX Travere Therapeutics, Inc. | Director | Grant | 6,500 | $0.00 | — | open → |
| 2026-05-07 | 2026-05-05 | TVTX Travere Therapeutics, Inc. | Sale | 4,500 | $209.9K | +41.6% | open → | |
| 2026-05-07 | 2026-05-05 | TVTX Travere Therapeutics, Inc. | Exer. | 4,500 | $82.2K | +261.6% | open → | |
| 2026-05-04 | 2026-05-01 | TVTX Travere Therapeutics, Inc. | Sale | 9,750 | $431.1K | +49.4% | open → | |
| 2026-05-04 | 2026-05-01 | TVTX Travere Therapeutics, Inc. | Exer. | 9,750 | $66.5K | +868.8% | open → | |
| 2025-11-21 | 2025-11-20 | NTRA Natera, Inc. | Sale | 1,884 | $423.7K | +45.9% | open → | |
| 2025-11-21 | 2025-11-20 | NTRA Natera, Inc. | Sale | 1,900 | $425.4K | +46.6% | open → | |
| 2025-11-21 | 2025-11-20 | NTRA Natera, Inc. | Sale | 1,800 | $401.2K | +47.2% | open → | |
| 2025-11-21 | 2025-11-20 | NTRA Natera, Inc. | Sale | 900 | $199.6K | +48.0% | open → | |
| 2025-11-21 | 2025-11-20 | NTRA Natera, Inc. | Sale | 1,184 | $260.6K | +49.1% | open → | |
| 2025-11-21 | 2025-11-20 | NTRA Natera, Inc. | Exer. | 7,068 | $291.1K | +696.7% | open → | |
| 2025-11-21 | 2025-11-20 | NTRA Natera, Inc. | Exer. | 600 | $24.6K | +701.8% | open → | |
| 2025-11-21 | 2025-11-19 | NTRA Natera, Inc. | Sale | 2,135 | $461.3K | +51.9% | open → | |
| 2025-11-21 | 2025-11-19 | NTRA Natera, Inc. | Sale | 1,727 | $370.9K | +52.8% | open → | |
| 2025-11-21 | 2025-11-19 | NTRA Natera, Inc. | Sale | 1,250 | $266.8K | +53.7% | open → | |
| 2025-11-21 | 2025-11-19 | NTRA Natera, Inc. | Exer. | 5,112 | $209.2K | +701.8% | open → | |
| 2025-11-04 | 2025-10-31 | NTRA Natera, Inc. | Grant | 93 | $0.00 | — | open → | |
| 2025-07-01 | 2025-06-27 | NTRA Natera, Inc. | Director | Grant | 2,143 | — | — | open → |
| 2025-07-29 | 2025-07-25 | NTRA Natera, Inc. | Director | Grant | 108 | — | — | open → |
